ANGO vs FOXA · rev $292.5M vs P/E 14, $24.50B cap
AngioDynamics Inc (ANGO) versus Fox Corp Class A (FOXA) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
FOXA does not have a complete income-statement cache yet.
ANGO currently screens at market cap $378.5M. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
Not investment advice. Open the ANGO and FOXA stock pages for the full models.
Not investment advice.